A Novel Polymorphic AP-1 Binding Element of the GFAP Promoter is Associated with Different Allelic Transcriptional Activities-Reference-Cited by-同舟云学术

A Novel Polymorphic AP-1 Binding Element of the GFAP Promoter is Associated with Different Allelic Transcriptional Activities

Published:2010-10-14 Issue:6 Volume:74 Page:506-515
ISSN:0003-4800
Container-title:Annals of Human Genetics
language:en
Short-container-title:

Author:

Bachetti Tiziana,Di Zanni Eleonora,Lantieri Francesca,Caroli Francesco,Regis Stefano,Filocamo Mirella,Rainero Innocenzo,Gallone Salvatore,Cilia Roberto,Romano Silvia,Savoiardo Mario,Pareyson Davide,Biancheri Roberta,Ravazzolo Roberto,Ceccherini Isabella

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1469-1809.2010.00614.x/fullpdf

Reference34 articles.

1. Mild functional effects of a novel GFAP mutant allele identified in a familial case of adult-onset alexander disease;Bachetti;Eur J Hum Genet,2008

2. Aspirin-induced blockade of NF-κB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells;Bae;Biochim Biophys Acta,2006

3. Haploview: analysis and visualization of LD and haplotype maps;Barret;Bioinformatics,2005

4. Structure and transcriptional regulation of the GFAP gene;Brenner;Brain Pathol,1994

5. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease;Brenner;Nat Genet,2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two novel GFAP mutations and genotype-phenotype associations in Alexander disease;2023-08-03

2. Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease;Frontiers in Pharmacology;2021-12-07

3. Regulation of GFAP Expression;ASN Neuro;2021-01

4. P38K and JNK pathways are induced by amyloid-β in astrocyte: Implication of MAPK pathways in astrogliosis in Alzheimer's disease;Molecular and Cellular Neuroscience;2020-10

5. Clinical characteristics of Alexander disease;Neurodegenerative Disease Management;2020-10